Laurete, Mailyn N.

HRN: 16-15-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2023
METRONIDAZOLE 500MG (TAB)
06/10/2023
06/17/2023
PO
500mg
TIDx7 Days
S/P LTCS; Thickly MSAF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: